PC
AVEO

PointState Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

PointState Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,000
Closed -$1.04M – 157
2015
Q2 		$1.04M Buy
+60,000
New +$1.08M 0.01% 138

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PointState Capital's AVEO Position: Q3 2015 in Review

PointState Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2015, closing a stake of 60,000 shares — an estimated $1.04M sold.

PointState Capital first reported a position in AVEO in Q2 2015 and held it in 1 quarter. The position peaked at $1.04M in Q2 2015. 48 funds tracked by Wall St. Rank hold AVEO as of Q3 2015.

  • PointState Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • PointState Capital sold 60,000 AVEO Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.04M.
  • PointState Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • PointState Capital's AVEO Pharmaceuticals, Inc. position peaked at $1.04M in Q2 2015.
  • 48 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2015.

Based on PointState Capital's 13F filing for Q3 2015, filed 16 Nov 2015.